Work

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

FWCI: 0.1
Cites: 1
Cited by: 4
Related to: 10